Rezultate clinice

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (se deschide o fereastră nouă)

Kantarjian HM, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Carpenter N, Mehta B, Franklin J, Giagounidis A

Sursă‎: Lancet Haematol 2018;5(3):e117-e126.

Index‎: PubMed 29396092

DOI‎: 10.1016/S2352-3026(18)30016-4

https://www.ncbi.nlm.nih.gov/pubmed/29396092 (se deschide o fereastră nouă)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (se deschide o fereastră nouă)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Sursă‎: Cancer 2013;119(1):107-14.

Index‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (se deschide o fereastră nouă)

HEMATOLOGIE

Rezultate clinice

Română

Rezultate clinice

https://assetsnffrgf-a.akamaihd.net/assets/ct/2208d1720a/images/syn_placeholder_sqr.png

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (se deschide o fereastră nouă)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (se deschide o fereastră nouă)

Contactați un reprezentant local al Comitetului de legătură cu spitalele

Materiale medicale informative

Materiale video

Rezultate clinice

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial. (se deschide o fereastră nouă)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (se deschide o fereastră nouă)

Contactați un reprezentant local al Comitetului de legătură cu spitalele

Materiale medicale informative

Materiale video

Selectaţi limba dorită

Partajează